Given that GSK-3β has been utilized as a marker for the diagnosis of GVHD (13), while no studies have confirmed that GSK-3β can modulate GVHD by regulating the differentiation and function of Breg cells. This evidence concerns the gene GSK3B and graft versus host disease.